Literature DB >> 1761573

Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state.

D W Riches1, G A Underwood.   

Abstract

The expression of cytocidal activity is induced by the sequential interaction of macrophages with a priming stimulus, such as interferon (IFN)alpha, -beta, or -gamma, and a triggering stimulus, such as poly(I.C) or lipopolysaccharide. However, most triggering stimuli are also capable of inducing IFN expression. This suggested to us the possibility that in addition to its role in initially priming macrophages for cytocidal activity, IFN may also be expressed during the triggering stage where it may potentially contribute to the regulation of cytocidal activity. We have explored this question by (i) attempting to dissociate IFN-inducing activity from triggering activity with a variety of structurally related and charge-related polyanions; (ii) determining if macrophages express IFN during the triggering stage; and (iii) questioning if IFN produced during the triggering stage contributes to the regulation of cytocidal activation. Exposure of unprimed macrophages to a triggering concentration of poly(I.C) alone failed to induce IFN beta expression. However, exposure of IFN beta-primed cells to poly(I.C) dramatically increased the expression of IFN beta mRNA. Priming with IFN gamma was likewise found to increase the expression of IFN beta mRNA in response to a triggering concentration of polyribonucleotides. Three approaches were adopted to ascertain if the increased expression of IFN beta contributed to cytocidal activation. First, macrophages derived from strains of mice which differ in their susceptibility to IFN induction by poly(I.C) were primed with IFN beta, washed, and triggered with poly(I.C). Under these conditions, macrophages derived from stain B10.A(2R), which are hyporesponsive to poly(I.C) in terms of IFN induction, also showed a diminished capacity to express Bf, a marker of cytocidal activation. Second, exposure of IFN-primed macrophages to poly(I.C) in the presence of anti-IFN alpha/beta antibody was found to reduce substantially the synthesis of NO2/NO3, an alternative marker of macrophage cytocidal activation. Third, exposure of IFN-primed macrophages to the calcium ionophores ionomycin or A23187, which do not induce the production of IFN beta during triggering, led to an abbreviated expression of Bf compared with stimuli that induce IFN beta expression such as poly(I.C). However, the capacity to synthesize Bf in response to A23187 was partially reconstituted when macrophages were triggered with the ionophore in the continuous presence of IFN beta. Collectively, these data show that IFN beta is expressed during the triggering stage of macrophage cytocidal activation and suggest that it plays an important and previously unsuspected role in the expression of this state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761573

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Regulation of chemokine expression by NaCl occurs independently of cystic fibrosis transmembrane conductance regulator in macrophages.

Authors:  Amanda G Kostyk; Karen M Dahl; Murry W Wynes; Laurie A Whittaker; Daniel J Weiss; Roberto Loi; David W H Riches
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages.

Authors:  E Guillemard; B Varano; F Belardelli; A M Quero; S Gessani
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Heat shock factor 1 protects against lung mycoplasma pneumoniae infection in mice.

Authors:  Fabienne Gally; Maisha N Minor; Sean K Smith; Stephanie R Case; Hong Wei Chu
Journal:  J Innate Immun       Date:  2011-10-26       Impact factor: 7.349

4.  Serum amyloid A protects murine macrophages from lethal toxin-mediated death.

Authors:  Kira Rose; Paul Long; Malini Shankar; Jimmy D Ballard; Carol F Webb
Journal:  Cell Immunol       Date:  2011-10-29       Impact factor: 4.868

5.  Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.

Authors:  Angela K Tollefson; Rebecca E Oberley-Deegan; Kiel T Butterfield; Michael E Nicks; Michael R Weaver; Linda K Remigio; Jessica Decsesznak; H W Chu; Donna L Bratton; David W Riches; Russell P Bowler
Journal:  Free Radic Biol Med       Date:  2010-09-29       Impact factor: 7.376

6.  Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages.

Authors:  B W Winston; C A Lange-Carter; A M Gardner; G L Johnson; D W Riches
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

8.  A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.

Authors:  W-M Qu; T Miyazaki; M Terada; K Okada; S Mori; H Kanno; M Nose
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states.

Authors:  D J Laszlo; P M Henson; L K Remigio; L Weinstein; C Sable; P W Noble; D W Riches
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.

Authors:  F R Lake; P W Noble; P M Henson; D W Riches
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.